APA (7th ed.) Citation

K, K., A, Z., D, B., K, S., LR, L., K, S., . . . M, A. (2026). Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha-Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer. Biomedicines, 14(2), . https://doi.org/10.3390/biomedicines14020263

Chicago Style (17th ed.) Citation

K, Khojayeva, Zhussipbekkyzy A, Balkybayeva D, Sabit K, Lopes LR, Sagatbekova K, Zhakupova A, and Aljofan M. "Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha-Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer." Biomedicines 14, no. 2 (2026). https://doi.org/10.3390/biomedicines14020263.

MLA (9th ed.) Citation

K, Khojayeva, et al. "Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha-Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer." Biomedicines, vol. 14, no. 2, 2026, https://doi.org/10.3390/biomedicines14020263.